Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 21909097)

1.

Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor.

Mata MA, Satterly N, Versteeg GA, Frantz D, Wei S, Williams N, Schmolke M, Peña-Llopis S, Brugarolas J, Forst CV, White MA, García-Sastre A, Roth MG, Fontoura BM.

Nat Chem Biol. 2011 Sep 11;7(10):712-9. doi: 10.1038/nchembio.645.

2.

Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner.

Walkiewicz MP, Basu D, Jablonski JJ, Geysen HM, Engel DA.

J Gen Virol. 2011 Jan;92(Pt 1):60-70. doi: 10.1099/vir.0.025015-0. Epub 2010 Sep 29.

3.

Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.

Hsu JT, Yeh JY, Lin TJ, Li ML, Wu MS, Hsieh CF, Chou YC, Tang WF, Lau KS, Hung HC, Fang MY, Ko S, Hsieh HP, Horng JT.

Antimicrob Agents Chemother. 2012 Feb;56(2):647-57. doi: 10.1128/AAC.00125-11. Epub 2011 Sep 19.

4.

Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.

Baughman BM, Jake Slavish P, DuBois RM, Boyd VA, White SW, Webb TR.

ACS Chem Biol. 2012 Mar 16;7(3):526-34. doi: 10.1021/cb200439z. Epub 2012 Jan 19.

5.

A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon.

Ortigoza MB, Dibben O, Maamary J, Martinez-Gil L, Leyva-Grado VH, Abreu P Jr, Ayllon J, Palese P, Shaw ML.

PLoS Pathog. 2012;8(4):e1002668. doi: 10.1371/journal.ppat.1002668. Epub 2012 Apr 26.

6.

HIV-protease inhibitors block the replication of both vesicular stomatitis and influenza viruses at an early post-entry replication step.

Federico M.

Virology. 2011 Aug 15;417(1):37-49. doi: 10.1016/j.virol.2011.05.002. Epub 2011 May 28.

7.

Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach.

Filone CM, Hodges EN, Honeyman B, Bushkin GG, Boyd K, Platt A, Ni F, Strom K, Hensley L, Snyder JK, Connor JH.

Chem Biol. 2013 Mar 21;20(3):424-33. doi: 10.1016/j.chembiol.2013.02.011.

8.

Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.

Shih SR, Chu TY, Reddy GR, Tseng SN, Chen HL, Tang WF, Wu MS, Yeh JY, Chao YS, Hsu JT, Hsieh HP, Horng JT.

J Biomed Sci. 2010 Feb 23;17:13. doi: 10.1186/1423-0127-17-13.

9.

Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export.

Zhang L, Das P, Schmolke M, Manicassamy B, Wang Y, Deng X, Cai L, Tu BP, Forst CV, Roth MG, Levy DE, García-Sastre A, de Brabander J, Phillips MA, Fontoura BM.

J Cell Biol. 2012 Feb 6;196(3):315-26. doi: 10.1083/jcb.201107058.

10.

Novel influenza virus NS1 antagonists block replication and restore innate immune function.

Basu D, Walkiewicz MP, Frieman M, Baric RS, Auble DT, Engel DA.

J Virol. 2009 Feb;83(4):1881-91. doi: 10.1128/JVI.01805-08. Epub 2008 Dec 3.

11.

Small interfering RNA targeting the nonstructural gene 1 transcript inhibits influenza A virus replication in experimental mice.

Rajput R, Khanna M, Kumar P, Kumar B, Sharma S, Gupta N, Saxena L.

Nucleic Acid Ther. 2012 Dec;22(6):414-22. doi: 10.1089/nat.2012.0359. Epub 2012 Oct 12.

PMID:
23062009
12.

Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases.

Krumm SA, Ndungu JM, Yoon JJ, Dochow M, Sun A, Natchus M, Snyder JP, Plemper RK.

PLoS One. 2011;6(5):e20069. doi: 10.1371/journal.pone.0020069. Epub 2011 May 16.

13.

Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma.

Kucejova B, Peña-Llopis S, Yamasaki T, Sivanand S, Tran TA, Alexander S, Wolff NC, Lotan Y, Xie XJ, Kabbani W, Kapur P, Brugarolas J.

Mol Cancer Res. 2011 Sep;9(9):1255-65. doi: 10.1158/1541-7786.MCR-11-0302. Epub 2011 Jul 28.

14.
15.

Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1.

Jablonski JJ, Basu D, Engel DA, Geysen HM.

Bioorg Med Chem. 2012 Jan 1;20(1):487-97. doi: 10.1016/j.bmc.2011.10.026. Epub 2011 Oct 19.

16.

Development of an HTS assay for the search of anti-influenza agents targeting the interaction of viral RNA with the NS1 protein.

Maroto M, Fernandez Y, Ortin J, Pelaez F, Cabello MA.

J Biomol Screen. 2008 Aug;13(7):581-90. doi: 10.1177/1087057108318754. Epub 2008 Jul 1.

PMID:
18594021
17.
18.

Inhibition of hepatitis C virus infection by polyoxometalates.

Qi Y, Xiang Y, Wang J, Qi Y, Li J, Niu J, Zhong J.

Antiviral Res. 2013 Nov;100(2):392-8. doi: 10.1016/j.antiviral.2013.08.025. Epub 2013 Sep 8.

PMID:
24025401
19.

Antiviral effect of octyl gallate against influenza and other RNA viruses.

Yamasaki H, Uozaki M, Katsuyama Y, Utsunomiya H, Arakawa T, Higuchi M, Higuti T, Koyama AH.

Int J Mol Med. 2007 Apr;19(4):685-8.

PMID:
17334645
20.

The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication.

de Chassey B, Aublin-Gex A, Ruggieri A, Meyniel-Schicklin L, Pradezynski F, Davoust N, Chantier T, Tafforeau L, Mangeot PE, Ciancia C, Perrin-Cocon L, Bartenschlager R, André P, Lotteau V.

PLoS Pathog. 2013;9(7):e1003440. doi: 10.1371/journal.ppat.1003440. Epub 2013 Jul 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk